$5.81
0.03[0.52%]
At close: Apr 26
$5.81
0[0.00%]
After Hours: 4:20PM EDT
AngioDynamics
(NASDAQ:ANGO)Latest News for AngioDynamics Stock (NASDAQ:ANGO)
AngioDynamics Stock (NASDAQ: ANGO)
Categories: All
Tuesday, April 09, 2024
Friday, April 05, 2024
Thursday, April 04, 2024
- Medical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock SoarsVandana Singh - Apr 4, 2024, 12:53PM
- CORRECTION: AngioDynamic Expects FY2024 Gross Margin To Be Approximately 52%-54% And Adjusted EPS of $(0.54) To $(0.58) Versus Consensus Of $(0.43)Benzinga Newsdesk - Apr 4, 2024, 12:13PM
- AngioDynamics shares are trading higher after the company received FDA 510(k) clearance For AlphaVac F1885 System For Pulmonary Embolism. Reported Q3 FY2024 earnings and issued FY2024 guidance.Benzinga Newsdesk - Apr 4, 2024, 7:09AM
- Angiodynamic Expects FY2024 Sales Of $270M-$275M, Reflects PICC And Midline Businesses Divestiture And Discontinuance Of RadioFrequency Ablation And Syntrax Businesses, Which Accounted For ~$50M Of Prior Guidance Of $320M-$325M Vs. Consensus Of $312.14MBenzinga Newsdesk - Apr 4, 2024, 7:06AM
- AngioDynamics Q3 Adjusted EPS $(0.16) Misses $(0.13) Estimate, Sales $75.18M Miss $75.73M EstimateBenzinga Newsdesk - Apr 4, 2024, 7:02AM
- AngioDynamics Secures 510(k) Clearance For AlphaVac F1885 System In Treatment Of Pulmonary EmbolismBenzinga Newsdesk - Apr 4, 2024, 6:46AM
- Earnings Scheduled For April 4, 2024Benzinga Insights - Apr 4, 2024, 5:18AM
Tuesday, April 02, 2024
Monday, April 01, 2024
Thursday, February 15, 2024
Tuesday, January 23, 2024
Tuesday, January 09, 2024
Monday, January 08, 2024
Friday, January 05, 2024
- Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Jan 5, 2024, 1:13PM
- Why Is Medical Devices-Focused AngioDynamics Stock Trading Lower Today?Vandana Singh - Jan 5, 2024, 10:35AM
- AngioDynamics shares are trading lower after the company lowered its FY24 guidance.Benzinga Newsdesk - Jan 5, 2024, 9:15AM
- US Stocks Poised To Extend New Year Slump As Focus Shifts To December Jobs Data: Analyst Sees S&P Testing 4,800 On This ConditionShanthi Rexaline - Jan 5, 2024, 7:36AM
- AngioDynamics Sees Adjusted EPS Loss Of $(0.35)-$(0.42) Versus Prior Guidance Of $(0.28)-$(0.34) And Consensus Of $(0.32)Benzinga Newsdesk - Jan 5, 2024, 7:10AM
- AngioDynamics Expects FY24 Sales Of $320M-$325M Versus Prior Guidance Of $328M-$333M And Consensus Of $329.05MBenzinga Newsdesk - Jan 5, 2024, 7:08AM
- AngioDynamics Q2 Adjusted EPS $(0.05) Beats $(0.07) Estimate, Sales $79.07M Miss $82.04M EstimateBenzinga Newsdesk - Jan 5, 2024, 7:04AM
- Investor Sentiment Edges Lower Ahead Of Jobs Report; Nasdaq Tumbles For 5th Consecutive DayAvi Kapoor - Jan 5, 2024, 5:24AM
- Costco Wholesale, Constellation Brands And 3 Stocks To Watch Heading Into FridayAvi Kapoor - Jan 5, 2024, 5:24AM
- Earnings Scheduled For January 5, 2024Benzinga Insights - Jan 5, 2024, 4:41AM
Thursday, January 04, 2024
Thursday, December 07, 2023
Friday, October 06, 2023
Thursday, October 05, 2023
- What 4 Analyst Ratings Have To Say About AngioDynamicsBenzinga Insights - Oct 5, 2023, 4:00PM
- Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $17Benzinga Newsdesk - Oct 5, 2023, 2:30PM
- HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $20Benzinga Newsdesk - Oct 5, 2023, 7:12AM
Wednesday, October 04, 2023
- Medical Devices Player AngioDynamics Exceeds Q1 Expectations, Sticks To Annual GuidanceVandana Singh - Oct 4, 2023, 2:09PM
- Stocks Rebound, Tech Shines As Bond Yields Relax, Oil Tumbles: What's Driving Markets Wednesday?Shanthi Rexaline - Oct 4, 2023, 1:52PM
- AngioDynamics Reaffirms FY24 Sales Of $328M-$333M Vs. Consensus Of $328.56M, Adjusted EPS Loss Of $(0.28)-$(0.34) Vs. Consensus Of $(0.32)Benzinga Newsdesk - Oct 4, 2023, 7:11AM
- AngioDynamics Q1 Adj. EPS $(0.12) Beats $(0.13) Estimate, Sales $78.68M Beat $77.69M EstimateBenzinga Newsdesk - Oct 4, 2023, 7:08AM
Tuesday, October 03, 2023
Monday, September 25, 2023
- AngioDynamics - Undervalued Gem In Med Tech: Analyst Eyes Stellar Growth With A 'Buy' StanceVandana Singh - Sep 25, 2023, 3:34PM
- Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023Benzinga Insights - Sep 25, 2023, 11:00AM
- HC Wainwright & Co. Initiates Coverage On AngioDynamics with Buy Rating, Announces Price Target of $19Benzinga Newsdesk - Sep 25, 2023, 6:14AM